721 related articles for article (PubMed ID: 22975043)
1. History to the discovery of ghrelin.
Bowers CY
Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH.
Roh SG; Doconto M; Feng DD; Chen C
Endocrine; 2006 Aug; 30(1):55-62. PubMed ID: 17185792
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-releasing peptides: clinical and basic aspects.
Argente J; García-Segura LM; Pozo J; Chowen JA
Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
[TBL] [Abstract][Full Text] [Related]
4. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
Yan M; Hernandez M; Xu R; Chen C
Eur J Endocrinol; 2004 Feb; 150(2):235-42. PubMed ID: 14763922
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
Bowers CY; Granda-Ayala R
Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
[TBL] [Abstract][Full Text] [Related]
6. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
Tannenbaum GS; Bowers CY
Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-releasing peptides.
Ghigo E; Arvat E; Muccioli G; Camanni F
Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
[TBL] [Abstract][Full Text] [Related]
8. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
9. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
10. On the actions of the growth hormone-releasing hexapeptide, GHRP.
Bowers CY; Sartor AO; Reynolds GA; Badger TM
Endocrinology; 1991 Apr; 128(4):2027-35. PubMed ID: 2004615
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone-releasing peptides and their analogs.
Camanni F; Ghigo E; Arvat E
Front Neuroendocrinol; 1998 Jan; 19(1):47-72. PubMed ID: 9465289
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pituitary GH reserve with GHRP-6.
Popovic V; Micic D; Damjanovic S; Djurovic M; Simic M; Gligorovic M; Dieguez C; Casanueva FF
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():289-98. PubMed ID: 8887173
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
[TBL] [Abstract][Full Text] [Related]
14. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
[TBL] [Abstract][Full Text] [Related]
15. Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH.
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Eur J Endocrinol; 2009 Nov; 161(5):681-6. PubMed ID: 19696160
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of human growth hormone and its secretagogues.
Root AW; Root MJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6.
Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963
[TBL] [Abstract][Full Text] [Related]
18. Age-related growth hormone-releasing activity of growth hormone secretagogues in humans.
Arvat E; Camanni F; Ghigo E
Acta Paediatr Suppl; 1997 Nov; 423():92-6. PubMed ID: 9401552
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
Cunha SR; Mayo KE
Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
[TBL] [Abstract][Full Text] [Related]
20. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
